These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 39032683)
1. HMGA2-mediated glutamine metabolism is required for Cd-induced cell growth and cell migration. Yang Y; Gao C; Li Q; Liu Y; Cao J Toxicology; 2024 Sep; 507():153899. PubMed ID: 39032683 [TBL] [Abstract][Full Text] [Related]
2. A novel HMGA2/MPC-1/mTOR signaling pathway promotes cell growth via facilitating Cr (VI)-induced glycolysis. Zhao S; Zhang Y; Bao S; Jiang L; Li Q; Kong Y; Cao J Chem Biol Interact; 2024 Aug; 399():111141. PubMed ID: 38992767 [TBL] [Abstract][Full Text] [Related]
3. A requirement for autophagy in HMGA2-induced metabolic reprogramming to support Cd-induced migration. Hasenbilige ; Mei J; Dlamini MB; Gao Z; Jiang L; Li Q; Geng C; Shi X; Liu Y; Kong Y; Cao J Toxicology; 2021 Oct; 462():152928. PubMed ID: 34481905 [TBL] [Abstract][Full Text] [Related]
4. ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells. Luo Y; Li W; Ling Z; Hu Q; Fan Z; Cheng B; Tao X Cancer Med; 2020 May; 9(10):3489-3499. PubMed ID: 32162845 [TBL] [Abstract][Full Text] [Related]
5. Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth. Ye J; Huang Q; Xu J; Huang J; Wang J; Zhong W; Chen W; Lin X; Lin X J Cancer Res Clin Oncol; 2018 May; 144(5):821-833. PubMed ID: 29435734 [TBL] [Abstract][Full Text] [Related]
6. Control of glutamine metabolism by the tumor suppressor Rb. Reynolds MR; Lane AN; Robertson B; Kemp S; Liu Y; Hill BG; Dean DC; Clem BF Oncogene; 2014 Jan; 33(5):556-66. PubMed ID: 23353822 [TBL] [Abstract][Full Text] [Related]
7. HMGA2 upregulation mediates Cd-induced migration and invasion in A549 cells and in lung tissues of mice. Luo H; Li Z; Ge H; Mei D; Zhao L; Jiang L; Geng C; Li Q; Yao X; Cao J Chem Biol Interact; 2017 Nov; 277():1-7. PubMed ID: 28830677 [TBL] [Abstract][Full Text] [Related]
8. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation. Cardoso HJ; Figueira MI; Vaz CV; Carvalho TMA; Brás LA; Madureira PA; Oliveira PJ; Sardão VA; Socorro S Cell Oncol (Dordr); 2021 Apr; 44(2):385-403. PubMed ID: 33464483 [TBL] [Abstract][Full Text] [Related]
9. LncRNA Jiang J; Dong W; Zhang W; Wang Q; Wang R; Wang J; Wu H; Dong H; Zhao RC; Wang J; Li Z Discov Med; 2023 Dec; 35(179):995-1014. PubMed ID: 38058065 [TBL] [Abstract][Full Text] [Related]
10. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer. Wang L; Liu Y; Zhao TL; Li ZZ; He JY; Zhang BJ; Du HZ; Jiang JW; Yuan ST; Sun L Phytomedicine; 2019 Apr; 57():117-128. PubMed ID: 30668314 [TBL] [Abstract][Full Text] [Related]
11. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JE; Holst J Oncogene; 2016 Jun; 35(24):3201-8. PubMed ID: 26455325 [TBL] [Abstract][Full Text] [Related]
12. ER stress-enhanced HMGA2 plays an important role in Cr (VI)-induced glycolysis and inhibited oxidative phosphorylation by targeting the transcription of ATF4. Luo S; Zhang C; Gao Z; Jiang L; Li Q; Shi X; Kong Y; Cao J Chem Biol Interact; 2023 Jan; 369():110293. PubMed ID: 36473502 [TBL] [Abstract][Full Text] [Related]
13. Targeting ASCT2-mediated glutamine metabolism inhibits proliferation and promotes apoptosis of pancreatic cancer cells. Wang W; Pan H; Ren F; Chen H; Ren P Biosci Rep; 2022 Mar; 42(3):. PubMed ID: 35237783 [TBL] [Abstract][Full Text] [Related]
14. Lobetyolin inhibits the proliferation of breast cancer cells Chen Y; Tian Y; Jin G; Cui Z; Guo W; Zhang X; Liu X Hum Exp Toxicol; 2021 Dec; 40(12):2074-2086. PubMed ID: 34075790 [TBL] [Abstract][Full Text] [Related]
16. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma. Zhang Z; Liu R; Shuai Y; Huang Y; Jin R; Wang X; Luo J Br J Cancer; 2020 Jan; 122(1):82-93. PubMed ID: 31819178 [TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression. Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652 [TBL] [Abstract][Full Text] [Related]
19. Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors via the transporter ASCT2. Zhou P; Liang X; Zhou C; Qin J; Hou C; Zhu Z; Zhang W; Wang S; Zhong D J Mater Chem B; 2019 Sep; 7(35):5363-5375. PubMed ID: 31403158 [TBL] [Abstract][Full Text] [Related]
20. ASCT2-mediated glutamine uptake promotes Th1 differentiation via ROS-EGR1-PAC1 pathway in oral lichen planus. Li W; Ling Z; Wang J; Su Z; Lu J; Yang X; Cheng B; Tao X Biochem Pharmacol; 2023 Oct; 216():115767. PubMed ID: 37634599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]